Compounds > diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)
Page last updated: 2024-11-08

diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one: a coupling reagent for mediating amide bond formation with little or no racemization; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID359472
MeSH IDM0128722
PubMed CID4293995
SCHEMBL ID76069
MeSH IDM0128722

Synonyms (59)

Synonym
diethoxybis(1-phenylbutane-1,3-dionato)titanium(iv)
nsc-620357
nsc620357
diethoxybis(1-phenyl-1,3-butanedionato-o,o')titanium
budotitanum [latin]
diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)
budotitano [spanish]
titanium, diethoxybis(1-phenyl-1,3-butanedionato)-
titanium, diethoxybis(1-phenyl-1,3-butanedionato-o,o')-, (17alpha,20e)-
titanium, diethoxybis(1-phenyl-1,3-butanedionato-kappao,kappao')-
ccris 2873
unii-dv05vzd83v
85969-07-9
budotitano
budotitanum
ethanolate;1-phenylbutane-1,3-dione;titanium(4+)
AC-7859
c11h14n3o5p
3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3h)-one, 98%
depbt
diethyl 3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl phosphate
165534-43-0
D3262
3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3h)-one
diethyl (4-oxo-1,2,3-benzotriazin-3-yl) phosphate
3-(diethoxyphosphoryloxy)-1,2,3-benzotrizin-4(3h)-one
AKOS015924149
FT-0613751
diethyl (4-oxobenzo[d][1,2,3]triazin-3(4h)-yl) phosphate
AM84565
diethyl 4-oxo-1,2,3-benzotriazin-3-yl phosphate
SCHEMBL76069
3-diethoxyphosphoryloxy-1,2,3-benzotriazin-4(3h)-one
AJDPNPAGZMZOMN-UHFFFAOYSA-N
diethyl 4-oxobenzo[d][1,2,3]triazin-3(4h)-yl phosphate
3-[(diethoxyphosphoryl)oxy]-1,2,3-benzotriazin-4(3h)-one
3-(diethoxyphosphoryloxy)-1,2,3-benzo-triazin-4(3h)-one
3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin4(3h)-one
3-(diethoxyphosphoryloxy)-(1,2,3)-benzotriazin-4(3h)-one
1,2,3-benzotriazin-4(3h)-one, 3-[(diethoxyphosphinyl)oxy]-
DTXSID10401645
mfcd01236967
J-510862
3-(diethoxy-phosphoryloxy)-1,2,3-benzo[d]triazin-4(3h)-one
3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3h)-one (depbt)
3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4-(3h)-one
AS-17341
Q19596789
phosphoric acid, diethyl 4-oxo-1,2,3-benzotriazin-3-yl ester
diethyl (4-oxobenzo[d][1,2,3]-triazin-3(4h)-yl) phosphate
diethyl(4-oxobenzo[d][1,2,3]triazin-3(4h)-yl)phosphate
diethyl (4-oxobenzo[d][1,2,3]triazin-3(4h)-yl) phosphate(depbt)
CS-W012140
3-((diethoxyphosphinyl)oxy)-1,2,3-benzotriazin-4(3h)-one
unii-z4jze73xnt
1,2,3-benzotriazin-4(3h)-one, 3-((diethoxyphosphinyl)oxy)-
z4jze73xnt ,
diethyl 4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl phosphate
EN300-7361897
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (22.22)18.7374
1990's4 (22.22)18.2507
2000's9 (50.00)29.6817
2010's1 (5.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Trials0 (0.00%)5.53%
Reviews3 (25.00%)6.00%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other8 (66.67%)84.16%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
dimethylnitrosamine
Dimethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.		1.9710nitrosaminegeroprotector;
mutagen
indazoles
Indazoles: A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES.		1.9710indazole
ethylnitrosourea
Ethylnitrosourea: A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.. N-ethyl-N-nitrosourea : A member of the class of N-nitrosoureas that is urea in which one of the nitrogens is substituted by ethyl and nitroso groups.		1.9710N-nitrosoureasalkylating agent;
carcinogenic agent;
genotoxin;
mutagen
ruthenium
Ruthenium: A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.		3.4820iron group element atom;
platinum group metal atom
titanium
Titanium: A dark-gray, metallic element of widespread distribution but occurring in small amounts with atomic number, 22, atomic weight, 47.867 and symbol, Ti; specific gravity, 4.5; used for fixation of fractures.		5.290titanium group element atom
hafnium
Hafnium: A metal element of atomic number 72 and atomic weight 178.49, symbol Hf.		1.9710titanium group element atom
zirconium
Zirconium: A rather rare metallic element with atomic number 40, atomic weight 91.224, and symbol Zr.		1.9710titanium group element atom
titanium dioxide
titanium dioxide: used medically as protectant against externally caused irritation & sunlight; high concentrations of dust may cause irritation to respiratory tract; RN given refers to titanium oxide (TiO2); structure. titanium dioxide : A titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications.		2.0110titanium oxidesfood colouring
methyl(acetoxymethyl)nitrosamine
methyl(acetoxymethyl)nitrosamine: RN given refers to parent cpd; structure in seventh source		1.9710
titanium isopropoxide
titanium(IV) isopropoxide : A titanium coordination entity consisting of a titanium(IV) cation with four propan-2-olate anions as counterions.		2.0310
aminotris(methylenephosphonato)diamminoplatinum (ii)
aminotris(methylenephosphonato)diamminoplatinum (II): structure given in first source		1.9710
titanocene
titanocene: C10-H10-Ti. titanocene : A bis(eta(5)-cyclopentadienyl)metal(II) having Ti(II) as the metal(II) species. The parent of the class of titanonocenes.		3.1210
guanidine
Guanidine: A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.. guanidine : An aminocarboxamidine, the parent compound of the guanidines.		3.110carboxamidine;
guanidines;
one-carbon compound
alanine
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.. alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.		3.110alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
sarin
Sarin: An organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.. isopropyl methylphosphonofluoridate : A phosphinic ester that is the isopropyl ester of methylphosphonofluoridic acid.. sarin : A racemate composed of equal amounts of (R)- and (S)-sarin. A potent and irreversible inhibitor of acetylcholinesterase that is toxic to the nervous system and is employed as a chemical warfare agent.		2.1310fluorine molecular entity;
phosphinic ester
lanthionine
lanthionine: a thioether analogue of cystine; RN given refers to (DL)-isomer; structure; a component of lantibiotics (BACTERIOCINS). lanthionine : An alanine derivative in which two alanine residues are linked on their beta-carbons by a thioether linkage.		3.110alanine derivative;
non-proteinogenic alpha-amino acid;
organic sulfide		bacterial metabolite
enkephalin, leucine
Enkephalin, Leucine: One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.. Leu-enkephalin : A pentapeptide comprising L-tyrosine, glycine, glycine, L-phenylalanine and L-leucine residues joined in sequence by peptide linkages. It is an endogenous opioid peptide produced in vertebrate species, including rodents, primates and humans that results from decomposition of proenkephalin or dynorphin and exhibits antinociceptive properties.		3.110pentapeptide;
peptide zwitterion		analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.9310
Cancer of Ovary
[description not available]		02.420
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.		02.420
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.		02.6630
Benign Neoplasms
[description not available]		03.7621
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		03.7621
Experimental Neoplasms
[description not available]		03.2920
Carcinoma 256, Walker
A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)		01.9610
Leukemia L 1210
[description not available]		01.9610
Leukemia P388
An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.		01.9610
Sarcoma 180
An experimental sarcoma of mice.		01.9610
Cancer of Colon
[description not available]		01.9710
Colonic Neoplasms
Tumors or cancer of the COLON.		01.9710